Liothyronine sodium
- Level
- Commodity
- Parent
- 51181600
- Below
- 0
- Links · KBLI
- 8
Definition
UNSPSC 51181627This classification denotes a generic primary tumor tnm finding with the molecular formula C15H11I3NO4.Na, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier GCA9VV7D2N, chemically known as l-tyrosine, o-(4-hydroxy-3-iodophenyl)-3,5-diiodo-, monosodium salt, but more generally known as liothyronine sodium, which bears US NIH Compound Identifier 5919. European Medicines Agency schedules liothyronine sodium or its base in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08527MIG. Most nations, for tariff purposes, schedule liothyronine sodium under HS 29374000. Liothyronine sodium bears US NLM identifiers UMLS ID C0546882 and NCI Concept Code C2581. SMILES: C1CC(C(CC1OC2C(CC(CC2I)C[C@@H](C(=O)[O-])N)I)I)O.[NA+].
Same parent
Under 51181600 · 29Activities that produce or sell this
KBLI · 8Inherited from family 51180000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.